SCHEMBL1001220

SCHEMBL1001220

COc1ccc(P(=O)(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 4/20 0.58
▸ CA2 P00918 4/20 0.58
▸ CA7 P43166 2/20 0.58
▸ CA9 Q16790 2/20 0.58
▸ CA12 O43570 1/20 0.58
▸ CA14 Q9ULX7 1/20 0.58
▸ ACHE P22303 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.46
▸ CYP2A6 P11509 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ CES2 O00748 1/20 0.46
▸ CES1 P23141 1/20 0.46
▸ TDP1 Q9NUW8 3/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ PLK1 P53350 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14339303 1.00 CA1 (0.58) CA1CA2CA7CA9CA12
SCHEMBL28368403 0.95 ESR2 (0.54) CA1CA2CA7CA9CA12
SCHEMBL5619254 0.91 CA4 (0.54) CA1CA2CA7CA9CA12
SCHEMBL5619896 0.91 CA4 (0.54) CA1CA2CA7CA9CA12
SCHEMBL5619669 0.91 ACHE (0.65) CA1CA2CA7CA9CA12
SCHEMBL5618905 0.91 ACHE (0.65) CA1CA2CA7CA9CA12
SCHEMBL4321300 0.89 NFE2L2 (0.53) CA1CA2CA7CA9CA12
SCHEMBL5966313 0.85 LTA4H (0.69) ALDH1A1PKMCES2CES1KDM4E
SCHEMBL14148854 0.85 LTA4H (0.63) ALDH1A1PKMCES2CES1NPC1
SCHEMBL14339306 0.84 HTT (0.44) CA1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119552054-A Preparation method and application of tricyclodecane monomethyl alcohol 广东华锦达新材科技有限公司 2025-03-04 — — CN claimed
CN-119101083-A Preparation method and application of cuprous halide-based fluorescent light-emitting material 华东师范大学 2024-12-10 — — CN claimed
CN-116082363-A Alkyl synthesis method of rapamycin 40-hydroxy 西安交通大学 2023-05-09 — — CN claimed
US-10815258-B2 Phosphine oxides reduction RHODIA OPERATIONS (FR) 2020-10-27 — — US claimed
US-20200231613-A1 PHOSPHINE OXIDES REDUCTION SPECIALTY OPERATIONS FRANCE (FR) 2020-07-23 — — US claimed
US-8962890-B1 Multifunctional crosslinkers for shape-memory polyimides, polyamides and poly(amide-imides) and methods of making the same THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2015-02-24 — — US claimed
US-8053605-B2 Phosphorus-containing catalyst composition and hydroformylation process using the same LG CHEM, LTD. (KR) 2011-11-08 — — US claimed
WO-2009035204-A1 PHOSPHORUS-CONTAINING CATALYST COMPOSITION AND HYDROFORMYLATION PROCESS USING THE SAME LG CHEM, LTD. (KR) 2009-03-19 — — WO claimed
US-4528403-A Hydroformylation process for preparation of aldehydes and alcohols MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1985-07-09 — — US claimed
CN-119913524-B Method for preparing phosphine oxide compound by clean and efficient electrochemical oxidation 南京工业大学 2026-05-19 — — CN disclosed
CN-116082363-B Alkyl synthesis method of rapamycin 40-hydroxy 西安交通大学 2025-11-21 — — CN disclosed
US-20250215205-A1 LOW DIELECTRIC RESIN COMPOSITION FOR IMPROVEMENT OF PROCESSABILITY, PREPREG AND METAL CLAD LAMINATE NAN YA PLASTICS CORPORATION (TW) 2025-07-03 — — US disclosed
US-20250215221-A1 LOW DIELECTRIC HIGH TG RESIN COMPOSITION FOR IMPROVEMENT OF PROCESSABILITY, PREPREG AND METAL CLAD LAMINATE NAN YA PLASTICS CORPORATION (TW) 2025-07-03 — — US disclosed
CN-119968094-A Hole transport composition, hole transport layer, preparation method of hole transport layer and perovskite battery 天合光能股份有限公司 2025-05-09 — — CN disclosed
EP-0272608-B1 PROCESS FOR THE HYDROFORMYLATION OF AN OLEFIN MITSUBISHI KASEI CORPORATION (JP) 1992-03-04 — — EP disclosed
US-5043487-A Butadiene and water with catalyst of triorganophosphine, triorganophosphine oxide and corbon dioxide BASF AKTIENGESELLSCHAFT (DE) 1991-08-27 — — US disclosed
US-4855087-A Process for the preparation of 2-chloroethanephosphonyl dichloride HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-08 — — US disclosed
US-4822917-A USING CATALYST OF RHODIUM COMPOUND AND TRIVALENT PHOSPHORUS COMPOUND MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1989-04-18 — — US disclosed
EP-0272608-A1 Process for the hydroformylation of an olefin MITSUBISHI KASEI CORPORATION (JP) 1988-06-29 — — EP disclosed
US-4528403-A Hydroformylation process for preparation of aldehydes and alcohols MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1985-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10815258-B2 Phosphine oxides reduction PHOSPHO1, PSPH, PTEN CA1 1128/4885CA2 1666/4885CA7 638/4885
US-20200231613-A1 PHOSPHINE OXIDES REDUCTION PHOSPHO1, PSPH, PTEN CA1 1128/4885CA2 1666/4885CA7 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback